Results: 62

For: antidepressants AND meta-analysis

Antidepressant discontinuation symptoms: what do the data really tell us?

julia-zolotova-5ZofAm1f27E-unsplash

Gemma Lewis and Glyn Lewis summarise a robust systematic review and meta-analysis investigating the incidence of symptoms when discontinuing or withdrawing from antidepressants. The data suggest that 8-14% of patients will experience antidepressant discontinuation symptoms, and for around 2% these symptoms will be severe.

[read the full story...]

Psychotherapy and antidepressant tapering can help people at risk of depression relapse, but more evidence needed before we can provide personalised treatment

reza-biazar-eSjmZW97cH8-unsplash

Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.

[read the full story...]

Antidepressants and psychotherapy for adolescent depression: can they be compared? #ActiveIngredientsMH

hendrik-kespohl-eD_YBIPNV3o-unsplash

Catherine Harmer summarises a recent network meta-analysis relating to her own Wellcome Trust funded research into antidepressants for young people with anxiety or depression.

[read the full story...]

In adults with major depression, antidepressants may increase the risk of suicide

shutterstock_409500925

Douglas Badenoch explores a meta-analysis of follow-up data from clinical trials of antidepressants, which found a small but significant increase in suicide risk.

[read the full story...]

Higher doses of antidepressants “not optimal”, according to new review

shutterstock_322041725

Jonathon Tomlinson considers his options as a GP supporting people with depression and complex needs, after reading a new systematic review and dose-response meta-analysis, which suggests that higher doses of antidepressants bring maximum side effects with only marginal gains.

[read the full story...]

Antidepressants can help adults with major depression

thought-catalog-567751-unsplash

André Tomlin reports on a new network meta-analysis that brings together the best available evidence comparing the efficacy and acceptability of 21 antidepressants for the acute treatment of adults with major depressive disorder.

This groundbreaking review of 522 trials is the largest ever meta-analysis in psychiatry, and finds that antidepressants are more effective than placebo for short-term treatment of acute depression in adults.

[read the full story...]

Antidepressants for depression in schizophrenia: when good-enough evidence is good enough

thought-catalog-505378

Carmine Pariante is positive about a recent systematic review and meta-analysis of antidepressants for the treatment of depression in schizophrenia.

[read the full story...]

Antidepressants for depression in Alzheimer’s Disease

mental-health-2211184_1280

The EQUATOR Publication School #EQPubSchool group summarise a systematic review and meta-analysis on the efficacy of antidepressants for depression in Alzheimer’s Disease, which finds no statistical difference between antidepressants and placebo.

[read the full story...]

Antidepressants for bipolar depression: weighing up the benefits and harms

7347845622_508b764a51_k

Murtada Alsaif considers a recent systematic review on the safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression.

[read the full story...]

One size does not fit all: divergent outcomes from CBT and antidepressants for depression

4417026016_b8ae7a8cec_b

Suzanne Dash explores a recent meta-analysis of CBT and antidepressants for depression, which looked at negative and positive responses to treatment and what predicted different outcomes.

[read the full story...]